Neuralink Receives FDA Go-Ahead for First Human Trials
Neuralink has received FDA approval to conduct its first human trials, indicating its potential to revolutionize the lives of individuals with neurological conditions and disabilities. Neuralink’s ambitious goal is to create a seamless connection between human brains and computers, enabling individuals to communicate and interact with machines in unprecedented ways.